The U.S. Food and Drug Administration’s advisory board is scheduled to vote on a dose of Johnson & Johnson’s COVID-19 stabbing on Friday, and the panel is expected to recommend that the FDA formally approve the injection emergency use approval in a race to vaccinate as many Americans as possible In the continuing fight against the new coronavirus
The jab is derived from an adenovirus vector formula, which is different from the vaccines manufactured by Moderna and Pfizer-BioNTech using mRNA technology, and has been approved for emergency use. The jab was found to have “good safety” , Did not find any specific problems”. The EUA is prohibited,”
In a global trial, the vaccine candidate proved to be 66.9% effective for moderate to severe diseases two weeks after vaccination. The company is seeking to obtain a license for personal use of 18 years and older.
If the committee approves the vaccine, and the FDA approves Johnson & Johnson injections for use in the United States, it will not immediately increase the supply of vaccines. Only a few million doses are expected to be shipped within the first week. But Johnson & Johnson told Congress this week that it expects to provide 20 million doses by the end of March and 100 million doses by the summer.
FDA EASES PFIZER COVID-19 vaccine transportation, storage temperature
However, “Once approved for emergency use, the Johnson & Johnson vaccine will become the third arrow in our quiver to defeat this terrible virus. More production means more people will be vaccinated-to reduce transmission, To quell the pandemic and reduce future deaths, Dr. Robert Amler, Dean of the School of Health Sciences and Practice of the New York School of Medicine and former Chief Medical Officer of the Centers for Disease Control and Prevention (CDC), recently told Fox News in an interview .
“Tulu College and University System Director and Physician” Dr. Alan Kadish added: “More vaccine supplies should help resolve the gap between the number of people eligible for vaccines and vaccine supply. This is good news.” Fox News.
Studies have shown that Pfizer and Moderna vaccines are 95% effective in preventing symptomatic COVID-19, which is more effective than J&J Jab’s 66.9%. Should Americans worry about which vaccine they will get, especially if the effectiveness of Johnson & Johnson declines?
Not exactly, Amler said.
How do we know the safety of the COVID-19 vaccine?
He suggested: “Let us look at the actual efficacy, not the efficacy reported from a study of a closely monitored population.” “The actual efficacy is affected by many other realistic factors not found in the study.”
Amler said, for example, Johnson & Johnson’s single-dose drug has an advantage over two-dose drugs simply because it is a single dose.
“Considering that all second-dose appointments are avoided, people will not forget or miss it. Consider the requirement of refrigeration that is much easier to transport and store vaccines than cryogenic freezing. Considering these practical factors, we can consider vaccines Almost equal.” He continued.
It is worth noting that the FDA said on Thursday that it allows Pfizer-BioNTech coronavirus vaccine to be more flexible in transportation and storage temperatures. The change allows transportation and two weeks of storage at -25 degrees Celsius to -15 degrees Celsius, which is common in medicine freezers and refrigerators.
When choosing a vaccine, if the country has ever reached a point where it can be selected, then the two experts have different reactions. Amler pointed out that “there is no need to choose” because “the FDA and CDC said there was no choice.” The preferred choice between the two vaccines currently approved for emergency use. “
What is the difference between mRNA vaccine and conventional Ones?
“I think that in the next few months, people should get any available vaccines, because they all have a considerable effect. It may be late summer or autumn, people will have a choice, then, we will have more Many choices. Data to determine whether one vaccine is better than another.” Kadish added.
Finally, considering that this is an experimental viral vector vaccine that uses a weakly live pathogen (adenovirus in this case), should anyone avoid using Johnson & Johnson’s prod?
Although Amler recommends waiting for official advice after obtaining official emergency use authorization, Kadish pointed out that due to the way the J&J vaccine was created, certain groups may need to avoid the J&J vaccine.
“Patients who are immunosuppressed or who may be pregnant should not get live performances [vaccine]”, Kadish said. But he pointed out that the allergic reactions of “Monaco” and “Pfizer” prodding “seems to be uncommon in Johnson & Johnson vaccines.” “
Click here for complete coronavirus coverage
However, both experts encourage qualified people to get vaccinated as soon as possible.
“Everyone should be vaccinated as soon as they get the vaccine, and they are eligible. If young people who are eligible for basic conditions feel embarrassed with the elderly, they should go beyond their embarrassment and be protected,” Amler suggested .
Kayla Rivas of Fox News and the Associated Press contributed to this report.